189 related articles for article (PubMed ID: 17523303)
21. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma.
Bañares R; Núñez O; Escudero M; Fernández C; Vaquero J; Beceiro I; Echenagusía A; Clemente G; Santos L
Hepatology; 2005 Mar; 41(3):566-71. PubMed ID: 15726654
[TBL] [Abstract][Full Text] [Related]
22. [Early hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: the risk factors and long-time survival].
Bai M; Han GH; Yuan SS; Yin ZX; He CY; Wang JH; Qi XS; Niu J; Guo WG; Wu KC; Fan DM
Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):498-501. PubMed ID: 22152239
[TBL] [Abstract][Full Text] [Related]
23. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.
Riggio O; Angeloni S; Salvatori FM; De Santis A; Cerini F; Farcomeni A; Attili AF; Merli M
Am J Gastroenterol; 2008 Nov; 103(11):2738-46. PubMed ID: 18775022
[TBL] [Abstract][Full Text] [Related]
24. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis.
Sigal SH; Stanca CM; Kontorinis N; Bodian C; Ryan E
Am J Gastroenterol; 2006 Jul; 101(7):1490-6. PubMed ID: 16863551
[TBL] [Abstract][Full Text] [Related]
25. Early diet intervention to reduce the incidence of hepatic encephalopathy in cirrhosis patients: post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) findings.
Luo L; Fu S; Zhang Y; Wang J
Asia Pac J Clin Nutr; 2016; 25(3):497-503. PubMed ID: 27440683
[TBL] [Abstract][Full Text] [Related]
26. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).
Routhu M; Safka V; Routhu SK; Fejfar T; Jirkovsky V; Krajina A; Cermakova E; Hosak L; Hulek P
Ann Hepatol; 2017; 16(1):140-148. PubMed ID: 28051803
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration.
Guevara M; Baccaro ME; Ríos J; Martín-Llahí M; Uriz J; Ruiz del Arbol L; Planas R; Monescillo A; Guarner C; Crespo J; Bañares R; Arroyo V; Ginès P
Liver Int; 2010 Sep; 30(8):1137-42. PubMed ID: 20602681
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation.
Kircheis G; Bode JG; Hilger N; Kramer T; Schnitzler A; Häussinger D
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1383-94. PubMed ID: 19738480
[TBL] [Abstract][Full Text] [Related]
29. Reversible hepatic decerebration: a case report and review of the literature.
Wehbe E; Saad D; Delgado F; Ta H; Antoun SA
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):759-60. PubMed ID: 19521243
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.
Riggio O; Masini A; Efrati C; Nicolao F; Angeloni S; Salvatori FM; Bezzi M; Attili AF; Merli M
J Hepatol; 2005 May; 42(5):674-9. PubMed ID: 15826716
[TBL] [Abstract][Full Text] [Related]
31. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
32. Transjugular intrahepatic portosystemic shunt prior to cardiac surgery with cardiopulmonary bypass in patients with cirrhosis and portal hypertension.
Semiz-Oysu A; Moustafa T; Cho KJ
Heart Lung Circ; 2007 Dec; 16(6):465-8. PubMed ID: 17446133
[TBL] [Abstract][Full Text] [Related]
33. Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt.
He F; Dai S; Xiao Z; Wang L; Yue Z; Zhao H; Zhao M; Lin Q; Dong X; Liu F
Biomed Res Int; 2016; 2016():3681731. PubMed ID: 27975051
[No Abstract] [Full Text] [Related]
34. No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Riggio O; Nardelli S; Pasquale C; Pentassuglio I; Gioia S; Onori E; Frieri C; Salvatori FM; Merli M
Metab Brain Dis; 2016 Dec; 31(6):1275-1281. PubMed ID: 26290375
[TBL] [Abstract][Full Text] [Related]
35. Hepatic encephalopathy.
Munoz SJ
Med Clin North Am; 2008 Jul; 92(4):795-812, viii. PubMed ID: 18570943
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
Albillos A; Bañares R; González M; Catalina MV; Molinero LM
J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
[TBL] [Abstract][Full Text] [Related]
37. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
[TBL] [Abstract][Full Text] [Related]
38. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study.
Sörös P; Böttcher J; Weissenborn K; Selberg O; Müller MJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):606-10. PubMed ID: 18005013
[TBL] [Abstract][Full Text] [Related]
39. Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.
Nardelli S; Gioia S; Pasquale C; Pentassuglio I; Farcomeni A; Merli M; Salvatori FM; Nikolli L; Torrisi S; Greco F; Nicoletti V; Riggio O
Am J Gastroenterol; 2016 Apr; 111(4):523-8. PubMed ID: 26925879
[TBL] [Abstract][Full Text] [Related]
40. Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus.
Deschênes M; Somberg KA
Am J Gastroenterol; 1998 Mar; 93(3):483. PubMed ID: 9517672
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
